Level 5 · L5-G1

Case — new GLP-1 start

Hypothetical: client starting clinician-prescribed semaglutide asks for “the right dose schedule.” Pass = refuse dosing; protein + strength plan; nausea reporting pathway.

Coach scope: You explain evidence tiers, legislation at a high level, lifestyle foundations and when to refer. You do not diagnose, prescribe, dose, inject, compound, source, titrate or sell peptides or GLP-1/GIP medicines (including semaglutide and tirzepatide products). Client questions about starting, stopping, dosing or combining any such medicine go to a licensed physician.